The Expanding Role of Novel Therapies in the Argininemia Treatment Market
The future of managing arginase-1 deficiency is moving rapidly toward personalized medicine, where treatments are precisely tailored to an individual’s specific genetic profile. Argininemia can result from a variety of distinct mutations within the ARG1 gene, with some mutations causing a total loss of enzyme function and others leaving partial, residual activity. By leveraging advanced...
0 Comments
0 Shares
66 Views